Literature DB >> 23184537

Expression of microRNAs associated with Gleason grading system in prostate cancer: miR-182-5p is a useful marker for high grade prostate cancer.

Katsuki Tsuchiyama1, Hideaki Ito, Minekatsu Taga, Seiji Naganuma, Yukinosuke Oshinoya, Ken-Ichi Nagano, Osamu Yokoyama, Hiroshi Itoh.   

Abstract

BACKGROUND: Expression profiles of some microRNAs (miRNAs) were associated with clinicopathological findings in human prostate cancer (PC), but the relative expression of miRNAs among Gleason patterns (GPs) remains unclear. In this study, we investigated the expression of several known microRNAs in each GP of PC.
METHODS: Formalin-fixed, paraffin embedded (FFPE) tissue samples were obtained from radical prostatectomy (RP) (patient set 1, n = 43, including (GP 3) n = 22, (GP 4) n = 35, and (GP 5) n = 12) and needle biopsy (patient set 2, n = 10, (GP 4) n = 10). Cancer tissues from each GP and adjacent normal counterparts were separately collected using laser-captured microdissection (LCM). Real-time RT-PCR was performed to determine the relative expression of miRNAs, including miR-31-5p, -34c-5p, -96-5p, -182-5p, -183-5p, -205-5p, -221-3p, and -222-3p, which were currently reported to be involved in PC progression.
RESULTS: In radical prostatectomy samples, relative expression of miR-31-5p, miR-34c-5p, and miR-205-5p in any GP was significantly decreased compared to normal counterpart. However, no significant difference was detected among GP 3, GP 4, and GP 5. Meanwhile, in the same GP4, expression of miR-31-5p miR-182-5p, and miR-205-5p in cancer tissues obtained from high grade cancer was significantly higher than those obtained from intermediate grade cancer. Validation study using biopsy samples revealed that the relative expression of miR-182-5p was statistically higher in high grade cancer even in same GP4.
CONCLUSIONS: We confirmed the expression of miR-182-5p depended on the cancer grade even in same GP 4. Expression of miRNA associated with Gleason grading system may contribute to more accurate preoperative cancer risk evaluation.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23184537     DOI: 10.1002/pros.22626

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  31 in total

1.  Epigenetic silencing of Kruppel like factor-3 increases expression of pro-metastatic miR-182.

Authors:  Mohit Sachdeva; Rebecca D Dodd; Zhiqing Huang; Carole Grenier; Yan Ma; Dina C Lev; Diana M Cardona; Susan K Murphy; David G Kirsch
Journal:  Cancer Lett       Date:  2015-08-24       Impact factor: 8.679

2.  Epithelial and stromal expression of miRNAs during prostate cancer progression.

Authors:  Qinghu Ren; Jiaqian Liang; Jianjun Wei; Olca Basturk; Jinhua Wang; Garrett Daniels; Lan Lin Gellert; Yirong Li; Ying Shen; Iman Osman; Jun Zhao; Jonathan Melamed; Peng Lee
Journal:  Am J Transl Res       Date:  2014-07-18       Impact factor: 4.060

3.  MicroRNA-182 drives metastasis of primary sarcomas by targeting multiple genes.

Authors:  Mohit Sachdeva; Jeffrey K Mito; Chang-Lung Lee; Minsi Zhang; Zhizhong Li; Rebecca D Dodd; David Cason; Lixia Luo; Yan Ma; David Van Mater; Rebecca Gladdy; Dina C Lev; Diana M Cardona; David G Kirsch
Journal:  J Clin Invest       Date:  2014-09-02       Impact factor: 14.808

4.  MiR-374b-5p suppresses RECK expression and promotes gastric cancer cell invasion and metastasis.

Authors:  Juan Xie; Zhi-Hui Tan; Xia Tang; Ming-Shu Mo; Yan-Ping Liu; Run-Liang Gan; Yi Li; Li Zhang; Guo-Qing Li
Journal:  World J Gastroenterol       Date:  2014-12-14       Impact factor: 5.742

5.  VDR regulation of microRNA differs across prostate cell models suggesting extremely flexible control of transcription.

Authors:  Prashant K Singh; Mark D Long; Sebastiano Battaglia; Qiang Hu; Song Liu; Lara E Sucheston-Campbell; Moray J Campbell
Journal:  Epigenetics       Date:  2015-01-29       Impact factor: 4.528

6.  Epigenetic analysis of laser capture microdissected fetal epithelia.

Authors:  Ratnam S Seelan; Dennis R Warner; Partha M Mukhopadhyay; Sarah A Andres; Irina A Smolenkova; James L Wittliff; M Michele Pisano; Robert M Greene
Journal:  Anal Biochem       Date:  2013-07-30       Impact factor: 3.365

Review 7.  Roles of miR-182 in sensory organ development and cancer.

Authors:  Qing Wei; Rong Lei; Guohong Hu
Journal:  Thorac Cancer       Date:  2015-01-07       Impact factor: 3.500

8.  MicroRNA-375 plays a dual role in prostate carcinogenesis.

Authors:  João Ramalho-Carvalho; Filipa Quintela Vieira; Carmen Jerónimo; Pedro Costa-Pinheiro; Jorge Torres-Ferreira; Jorge Oliveira; Céline S Gonçalves; Bruno M Costa; Rui Henrique
Journal:  Clin Epigenetics       Date:  2015-04-10       Impact factor: 6.551

9.  The Downregulation of MiR-182 Is Associated with the Growth and Invasion of Osteosarcoma Cells through the Regulation of TIAM1 Expression.

Authors:  Jun Hu; Guohua Lv; Shuguang Zhou; Yucheng Zhou; Bangxu Nie; Hong Duan; Yunfeng Zhang; Xiaofeng Yuan
Journal:  PLoS One       Date:  2015-05-14       Impact factor: 3.240

10.  Identification and Validation of a Five MicroRNA Signature Predictive of Prostate Cancer Recurrence and Metastasis: A Cohort Study.

Authors:  Robert K Nam; Yutaka Amemiya; Tania Benatar; Christopher J D Wallis; Jessica Stojcic-Bendavid; Stephanie Bacopulos; Christopher Sherman; Linda Sugar; Magda Naeim; Wenyi Yang; Aiguo Zhang; Laurence H Klotz; Steven A Narod; Arun Seth
Journal:  J Cancer       Date:  2015-09-15       Impact factor: 4.207

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.